BRNS

COM:BARINTHUSBIO

Barinthus Biotherapeutics plc

  • Stock

Last Close

1.49

08/11 21:00

Market Cap

55.90M

Beta: -

Volume Today

43.85K

Avg: -

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. It is advancing a pipeline of product candidates across a range of therapeutic areas, including VTP-300, an immunotherapeutic candidate designed as a potenti...Show More

peer of